Literature DB >> 3012597

Opiate blockade inhibits saccharin intake and blocks normal preference acquisition.

W C Lynch.   

Abstract

Recent evidence indicates a close connection between oral sensory function and opioid effects on feeding. Not only is gustatory motivation influenced by opiate drugs but apparently gustatory stimuli can also activate central opiate receptor systems. In 3 experiments we studied the effect of opiate receptor blockade on drinking motivated by the sweet taste of saccharin. Experiment 1 established a dose-response function for inhibition of intake by naloxone (NAL) in short (60 min) 2-bottle tests. This experiment demonstrated the extreme sensitivity of nondeprived, nonstressed animals to NAL and estimated the MED50 at less than 0.1 mg/kg (SC), well below the threshold for effects due to illness or general motor disturbance. Experiment 2 further demonstrated that NAL's effectiveness depends on saccharin concentration. In particular, the lowest NAL dose studied was effective near the threshold for saccharin preference but not at higher concentrations. These data suggest that endogenous opioid systems may be activated by taste stimuli in a graded fashion. Finally, experiment 3 showed that the typical acquisition of preference for a moderate saccharin concentration can be effectively blocked by daily pre-test NAL injection. Together these experiments further demonstrate the close functional relationship between opioid systems and gustatory sensory systems.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012597     DOI: 10.1016/0091-3057(86)90420-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  13 in total

1.  Selective reward deficit in mice lacking beta-endorphin and enkephalin.

Authors:  Michael D Hayward; John E Pintar; Malcolm J Low
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

2.  Reduced alcohol consumption in mice lacking preprodynorphin.

Authors:  Yuri A Blednov; Danielle Walker; Marni Martinez; R Adron Harris
Journal:  Alcohol       Date:  2006-10       Impact factor: 2.405

3.  Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.

Authors:  Nathan A Holtz; Anna K Radke; Natalie E Zlebnik; Andrew C Harris; Marilyn E Carroll
Journal:  Brain Res       Date:  2015-01-09       Impact factor: 3.252

4.  Effects of a selective mu opioid receptor agonist and naloxone on the intake of sodium chloride solutions.

Authors:  B A Gosnell; M J Majchrzak
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Naloxone administration following operant training of sucrose/water discrimination in the rat.

Authors:  E O O'Hare; J Cleary; P J Bartz; D T Weldon; C J Billington; A S Levine
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

Review 6.  Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens.

Authors:  Ryan A Selleck; Brian A Baldo
Journal:  Psychopharmacology (Berl)       Date:  2017-01-04       Impact factor: 4.530

Review 7.  Feeding, drug abuse, and the sensitization of reward by metabolic need.

Authors:  K D Carr
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

8.  Norbinaltorphimine blocks the feeding but not the reinforcing effect of lateral hypothalamic electrical stimulation.

Authors:  K D Carr; V Papadouka; T D Wolinsky
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Naloxone effects on sucrose-motivated behavior.

Authors:  J Cleary; D T Weldon; E O'Hare; C Billington; A S Levine
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

10.  The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference.

Authors:  S Krishnan-Sarin; S L Jing; D L Kurtz; M Zweifel; P S Portoghese; T K Li; J C Froehlich
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.